Trier par :

22-DCC-35
regarding the exclusive control acquisition of the company Bio Pôle Antilles by the Inovie group

Merger control

|

Meaning of the decision issued on:

Sector(s) :

Healthcare

21-DCC-131
regarding the exclusive acquisition of Oriade-Noviale by Biogroup

Merger control

|

Meaning of the decision issued on:

Sector(s) :

Healthcare

21-DCC-86
regarding the exclusive control acquisition of the C2S clinics by Elsan group

Merger control

|

Meaning of the decision issued on:

Sector(s) :

Healthcare

20-DCC-63
regarding the sole control acquisition of Sinoué group by Orpea group

Merger control

|

Meaning of the decision issued on:

Sector(s) :

Healthcare

20-DCC-38
regarding the sole control acquisition of Hexagone Santé Méditerranée company and SCI Bonnefon-Carnot by the Elsan group

Merger control

|

Meaning of the decision issued on:

Sector(s) :

Healthcare

19-DCC-267
regarding the sole control acquisition of Laboratoires Iprad Santé and Laboratoires Iprad Pharma companies by Biocodex company

Merger control

|

Meaning of the decision issued on:

Sector(s) :

Healthcare

19-DCC-244
regarding exclusive control acquisition of Audilab company and its subsidiaries by William Demant group

Merger control

|

Meaning of the decision issued on: